| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 21382-82-1 | 2-三苯基膦乙烯基丙酸乙酯（索非布韦中间体-1） | triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane | C23H23O2P | 362.4 | | |
| 21382-90-1 | | Methanaminium,N-(chloromethylene)-N-methyl-,phosphorodichloridate | C3H7Cl3NO2P | 226.43 | | |
| 21382-98-9 | 4-(甲基硫代)苯甲腈 | 4-Cyanothioanisole | C8H7NS | 149.21 | 61-63℃ | 272℃ |
| 2138212-72-1 | N-(oxetan-3-yl)azetidin-3-amine;bis(2,2,2-trifluoroacetic acid) | | C6H12N2O.2[C2HO2F3] | 356.2184 | | |
| 2138226-21-6 | 2-(((9H-芴-9-基)甲氧基)羰基)-1,2,3,4-四氢异喹啉-6-羧酸 | 2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | C25H21NO4 | 399.44 | | 622.0±55.0 °C(Predicted) |
| 2138238-83-0 | 4-(氟磺酰基)-1-甲基-1H-吡咯-2-羧酸 | 4-(Fluorosulfonyl)-1-methyl-1H-pyrrole-2-carboxylic acid | C6H6FNO4S | 207.18 | | |
| 2138261-08-0 | 3,3-二甲基-2-氧杂螺[4.5]癸烷-8-胺盐酸盐 | 3,3-dimethyl-2-oxaspiro[4.5]decan-8-amine hydrochloride | | | | |
| 2138261-93-3 | tert-butyl 6-acetyl-1,4-oxazepane-4-carboxylate | | C12H21NO4 | 243.2986 | | |
| 2138271-93-7 | 2-(3-氨基氧杂环丁-3-基)乙-1-醇盐酸盐 | 2-(3-aminooxetan-3-yl)ethan-1-olhydrochloride | C5H12ClNO2 | 153.61 | | |
| 2138280-09-6 | 1-(2-溴乙基)-4,4-二氟哌啶氢溴酸盐 | 1-(2-Bromoethyl)-4,4-difluoropiperidine hydrobromide | C7H13Br2F2N | 308.99 | | |
| 2138299-29-1 | STING agonist-3 | | C37H42N12O6 | 750.81 | | |
| 2138299-33-7 | STING agonist compound 3 | | C42H51N13O7 | 849.95 | | |
| 2138299-34-8 | STING agonist-1（compound 3）trihydrochloride | | C42H54Cl3N13O7 | 959.32 | | |
| 21383-00-6 | 3-氯苯基甲砜 | 3-chlorophenyl methyl sulfone | C7H7ClO2S | 190.65 | | |
| 2138300-40-8 | STING agonist-4 | | C34H38N12O4 | 678.74 | | |
| 2138302-17-5 | 3-(3-甲氧基丙氧基)-4-氯-5-硝基苯甲酰胺 | 4-chloro-3-(3-methoxypropoxy)-5-nitrobenzamide | | | | |
| 213831-00-6 | n-(3-氨基苯基)-2-甲基丙酰胺 | n-(3-aminophenyl)-2-methylpropanamide | | | | |
| 2138328-00-2 | Isobutyl 3-(5-((1R,2S)-2-(2,2-difluoropropanamido)-1-phenylpropoxy)-1H-indazol-1-yl)benzoate | | C30H31F2N3O4 | 535.591 | | |
| 213833-68-2 | 8-碘-1,4-二氧杂螺[4.5]癸烷 | 8-Iodo-1,4-dioxa-spiro[4.5]decane | C8H13IO2 | 268.09 | | |
| 2138330-46-6 | 3-(1,2,2-三苯基乙烯基)苯甲醛 | 3-(1,2,2-Triphenylvinyl)benzaldehyde | C27H20O | 360.45 | | |
| 2138337-19-4 | 1-嘧啶-2-乙胺 | 1-Pyrimidin-2-ylethanamine | C6H10ClN3 | 159.62 | | |
| 2138349-88-7 | n,n-二苄基-dl-丝氨酸苄酯 | n,n-dibenzyl-dl-serine benzyl ester | | | | |
| 2138361-09-6 | 1-甲基-2-氧杂双环[2.2.2]辛烷-4??-羧酸 | 1-methyl-2-oxabicyclo[2.2.2]octane-4-carboxylicacid,Mixtureofdiastereomers | C9H14O3 | 170.21 | | 283.9±23.0 °C(Predicted) |
| 2138364-29-9 | 1,3-二环丁基丙烷-1,3-二酮 | 1,3-Propanedione,1,3-dicyclobutyl- | C11H16O2 | 180.24 | | |
| 2138386-72-6 | 3-氯-4,5,6,7-四氢吡唑并[1,5-a]吡啶 | 3-Chloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine | C7H9ClN2 | 156.61 | | |
| 21384-53-2 | | methyl 1-benzylaziridine-2-carboxylate | | | | |
| 21384-57-6 | | 1-(1-naphthylcarbamoyl)-2-aziridinecarboxylic aci ethyl ester | | | | |
| 2138402-24-9 | 3-溴-5-(氟磺酰基)苯甲酸 | 3-Bromo-5-(fluorosulfonyl)benzoic acid | C7H4BrFO4S | 283.07 | | 409.6±40.0 °C(Predicted) |
| 2138411-43-3 | 2-(吡咯烷-3-基)吡啶二盐酸盐 | 2-(Pyrrolidin-3-yl)pyridine dihydrochloride | C9H14Cl2N2 | 221.1269 | | |
| 213843-90-4 | | (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine | C33H34NO4P | 539.60 | 218-221 ℃ | 569.804°C |
| 213843-95-9 | 1-[(3ar,8ar)-四氢-2,2-二甲基-4,4,8,8-四苯基-1,3-二噁唑并[4,5-e][1,3,2]二噁膦杂庚英-6-基]哌啶 | 1-[(3ar,8ar)-tetrahydro-2,2-dimethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]- piperidine | C36H38NO4P | 579.66 | | |
| 2138438-15-8 | 1-azabicyclo[2.2.1]heptan-4-ylmethanol;hydrochloride | | C7H13NO.HCl | 163.6446 | | |
| 2138439-12-8 | Thalidomide-NH-PEG1-NH2 | | C17H20N4O5 | 360.36 | | |
| 2138439-53-7 | (S,R,S)-AHPC-C4-NH2 | | C27H39N5O4S | 529.69 | | |
| 2138439-56-0 | 2-(2,6-二氧代哌啶-3-基)-4-((2-(2-(丙-2-炔-1-基氧基)乙氧基)乙基)氨基)异吲哚啉-1,3-二酮 | 2-(2,6-Dioxopiperidin-3-yl)-4-((2-(2-(prop-2-yn-1-yloxy)ethoxy)ethyl)amino)isoindoline-1,3-dione | C20H21N3O6 | 399.4 | | |
| 2138440-81-8 | | pomalidomide-peg4-co2h | C24H31N3O10 | 521.52 | | |
| 2138440-82-9 | | pomalidomide-peg3-co2h | C22H27N3O9 | 477.46 | | |
| 2138441-29-7 | tert-Butyl N-[2-[3-[2-(2,6-dioxo-3-piperidyl)-1,3-dioxoisoindolin-4-yl]propoxy]ethyl]carbamate | | C23H29N3O7 | 459.499 | | |
| 2138467-53-3 | 2-([1,1-联苯]-4-基)-4-氯-6-(萘-1-基)-1,3,5-三嗪 | 2-([1,1-Biphenyl]-4-yl)-4-Chloro-6-(Naphthalene-1-yl)-1,3,5-Triazine | C25H16ClN3 | 393.87 | | |
| 2138471-81-3 | 2-六甘醇乙基甲基醚-异吲哚啉-1,3-二酮 | 2-hexaethylene glycol ethyl methyl ether-isoindoline-1,3-dione | C23H35NO9 | 469.53 | | |
| 2138482-09-2 | | n-fmoc-n-methyl-3-(2-naphthyl)-l-alanine | C29H25NO4 | 451.52 | | 665.9±44.0 °C at 760 mmHg |
| 2138484-13-4 | Boc-NH-PEG4-C2-Boc | | C20H39NO8 | 421.53 | | |
| 2138490-93-2 | 2-(6-氯二苯并[b,d]呋喃-1-基)-4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷 | 2-(6-Chlorodibenzo[b,d]furan-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C18H18BClO3 | 328.6 | | 454.2±25.0 °C(Predicted) |
| 2138491-47-9 | [1,3-双[2,6-双[3-甲基-1-(2-甲基丙基)丁基]苯基]-4,5-二氯-1,3-二氢-2H-咪唑-2-亚甲基]氯[(1,2,3-η)-1-苯基-2-丙烯-1-基]-钯 | [1,3-Bis[2,6-bis[3-methyl-1-(2-methylpropyl)butyl]phenyl]-4,5-dichloro-1,3-dihydro-2H-imidazol-2-ylidene]chloro[(1,2,3-η)-1-phenyl-2-propen-1-yl]-Palladium | C60H91Cl3N2Pd | 1053.16 | | |
| 2138496-98-5 | | tbdi-dfbt | | | | |
| 2138498-18-5 | diABZISTINGagonist-1Tautomerism | diABZI STING agonist-1 Tautomerism | C42H51N13O7 | 849.94 | | |
| 2138499-06-4 | Abemaciclib metabolite M20 | | C27H32F2N8O | 522.59 | | |
| 2138507-91-0 | 1-环丁基丙-1-胺盐酸盐 | 1-Cyclobutylpropan-1-amine hydrochloride | C7H16ClN | 149.66 | | |
| 2138516-43-3 | tert-butyl N-(1H-indazol-7-ylmethyl)carbamate | | C13H17N3O2 | 247.2923 | | |
| 2138531-08-3 | | n-boc-3-bromobenzyl-glycine | | | | |
m.cnreagent.com